Deutsche Bank’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,328
Closed -$34.9K 3749
2025
Q1
$34.9K Hold
30,328
﹤0.01% 3431
2024
Q4
$66.4K Hold
30,328
﹤0.01% 3377
2024
Q3
$66.1K Buy
30,328
+12,603
+71% +$29K ﹤0.01% 3307
2024
Q2
$40.9K Sell
17,725
-5,378
-23% -$22.3K ﹤0.01% 3357
2024
Q1
$127K Buy
23,103
+14,846
+180% +$67.9K ﹤0.01% 3052
2023
Q4
$20.4K Sell
8,257
-93,651
-92% -$889K ﹤0.01% 3490
2023
Q3
$3.54M Sell
101,908
-13,950
-12% -$482K ﹤0.01% 1142
2023
Q2
$3.8M Buy
115,858
+19,402
+20% +$669K ﹤0.01% 1338
2023
Q1
$3.23M Buy
96,456
+83,375
+637% +$3.24M ﹤0.01% 1431
2022
Q4
$429K Buy
13,081
+3,116
+31% +$92.3K ﹤0.01% 2537
2022
Q3
$348K Sell
9,965
-1,189
-11% -$26.3K ﹤0.01% 2607
2022
Q2
$137K Buy
11,154
+5,489
+97% +$82K ﹤0.01% 3369
2022
Q1
$77K Sell
5,665
-680
-11% -$9.09K ﹤0.01% 3679
2021
Q4
$126K Buy
+6,345
New +$120K ﹤0.01% 3601

Other funds holding VTYX

Deutsche Bank's VTYX Position: Q2 2025 in Review

Deutsche Bank sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 30,328 shares — an estimated $34.9K sold.

Deutsche Bank first reported a position in VTYX in Q4 2021 and held it in 14 quarters. The position peaked at $3.8M in Q2 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Deutsche Bank reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 30,328 Ventyx Biosciences shares in Q2 2025, an estimated $34.9K.
  • Deutsche Bank first reported a position in Ventyx Biosciences in Q4 2021 and held it in 14 quarters.
  • Deutsche Bank's Ventyx Biosciences position peaked at $3.8M in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.